<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN) — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN)</h2>
    <div class="badge">2025-09-15T12:15:29+00:00</div>
    <ul>
      <li>(NASDAQ:REGN) with a price target of $640.</li>
<li>READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.</li>
<li>On September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc.</li>
<li>Disclosure: None.</li>
<li>Regeneron Pharmaceuticals, Inc.</li>
<li>This article is originally published at Insider Monkey.</li>
<li>Seigerman notes the clinical data address a large unmet medical need.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN)\n• (NASDAQ:REGN) with a price target of $640.\n• READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.\n• On September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc.\n• Disclosure: None.\n• Regeneron Pharmaceuticals, Inc.\n• This article is originally published at Insider Monkey.\n• Seigerman notes the clinical data address a large unmet medical need." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/bmo-capital-maintains-buy-regeneron-121529852.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>